Guardant Health logo
Guardant Health GH
$ 32.76 5.75%

Quarterly report 2024-Q3
added 11-06-2024

report update icon

Guardant Health Balance Sheet 2011-2024 | GH

Annual Balance Sheet Guardant Health

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

34.4 M 1.02 B 655 M -20.1 M -103 M -140 M -71.6 M -16.6 M - - - - -

Long Term Debt

1.14 B 1.14 B 1.13 B 806 M - - - 16.5 M - - - - -

Long Term Debt Current

28 M 21.9 M 12.9 M 6.63 M 7.14 M - - - - - - - -

Total Non Current Liabilities

- - - - 91.4 M 57.3 M 14.7 M 22.6 M - - - - -

Total Current Liabilities

206 M 193 M 195 M 66.8 M 72.7 M 46.9 M - - - - - - -

Total Liabilities

1.63 B 1.55 B 1.56 B 973 M 164 M 104 M 34.3 M 36.9 M - - - - -

Deferred Revenue

18 M 17.4 M 11.3 M 8.55 M 12.3 M 16.1 M 3.11 M 1.9 M - - - - -

Retained Earnings

-2.14 B -1.66 B -1.01 B -607 M -353 M -281 M -196 M -108 M - - - - -

Total Assets

1.79 B 1.61 B 2.2 B 2.27 B 963 M 587 M 343 M 117 M - - - - -

Cash and Cash Equivalents

1.13 B 142 M 492 M 833 M 143 M 141 M 72.6 M 33.6 M - - - - -

Book Value

159 M 60.2 M 645 M 1.3 B 798 M 483 M 309 M 79.7 M - - - - -

Total Shareholders Equity

159 M 60.2 M 645 M 1.3 B 798 M 483 M 309 M 79.7 M - - - - -

All numbers in USD currency

Quarterly Balance Sheet Guardant Health

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

1.14 B 1.14 B 1.14 B 1.14 B 1.14 B 1.14 B 1.14 B 1.14 B 1.14 B - 1.14 B 1.13 B 1.13 B 1.13 B 1.13 B 806 M 806 M 806 M 806 M - 33.3 M 33.3 M 33.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

1.6 B 1.61 B 1.64 B 1.63 B 1.57 B 1.55 B 1.56 B 1.55 B 1.54 B - 1.6 B 1.56 B 1.46 B 1.44 B 1.44 B 916 M 916 M 916 M 916 M 115 M 115 M 115 M 115 M 62.5 M 62.5 M 62.5 M 62.5 M 34.3 M 34.3 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

29.6 M 29.4 M 22.6 M 18 M 21.5 M 12.2 M 13.6 M 17.4 M 13.4 M - 10.6 M 11.3 M 7.32 M 8.48 M 8.36 M 8.55 M 7.34 M 8.55 M 11.9 M 12.3 M 13.1 M 16.5 M 12.3 M 16.1 M 16.1 M 16.1 M 16.1 M 3.11 M 3.11 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-2.47 B -2.36 B -2.26 B -2.14 B -1.95 B -1.87 B -1.8 B -1.66 B -1.52 B - -1.13 B -1.01 B -917 M -809 M -712 M -607 M -607 M -607 M -607 M -353 M -353 M -353 M -353 M -281 M -281 M -281 M -281 M -196 M -196 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

1.54 B 1.61 B 1.7 B 1.79 B 1.8 B 1.84 B 1.51 B 1.61 B 1.7 B - 2.13 B 2.2 B 2.23 B 2.29 B 2.35 B 2.27 B 2.27 B 2.27 B 2.27 B 963 M 963 M 963 M 963 M 587 M 587 M 587 M 587 M 343 M 343 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

585 M 934 M 1.03 B 1.13 B 457 M 271 M 224 M 142 M 158 M 215 M 574 M 492 M 832 M 939 M 869 M 833 M 833 M 833 M 833 M 143 M 143 M 143 M 143 M 141 M 141 M 141 M 141 M 72.3 M 72.3 M - - 33.6 M - - - 4.26 M - - - - - - - - - - - - - - - - - - -

Book Value

-60.1 M -1.61 M 68.3 M 159 M 228 M 293 M -44.6 M 60.2 M 167 M - 533 M 645 M 769 M 847 M 906 M 1.36 B 1.36 B 1.36 B 1.36 B 848 M 848 M 848 M 848 M 525 M 525 M 525 M 525 M 309 M 309 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

-60.1 M -1.61 M 68.3 M 159 M 228 M 293 M -44.6 M 60.2 M 167 M 319 M 533 M 645 M 709 M 788 M 847 M 1.3 B 1.3 B 1.3 B 1.3 B 798 M 798 M 798 M 798 M 483 M 483 M 483 M 483 M 309 M 309 M - - 79.7 M - - - 83.4 M - - - - - - - - - - - - - - - - - - -

All numbers in USD currency